berk-additionoffluoxetine-2014.pdf (443.34 kB)
Download fileThe addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
journal contribution
posted on 2014-01-01, 00:00 authored by C G Davey, A M Chanen, S M Cotton, S E Hetrick, M J Kerr, Michael BerkMichael Berk, Olivia DeanOlivia Dean, K Yuen, M Phelan, A Ratheesh, M R Schäfer, G P Amminger, A G Parker, D Piskulic, S Harrigan, A J Mackinnon, B J Harrison, P D McGorryThe aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised by meta-analyses in which the efficacy and safety of antidepressants in young people have been questioned, and subsequent treatment guidelines for youth depression have provided only qualified support.
History
Journal
TrialsVolume
15Article number
425Pagination
1 - 9Publisher
BioMed CentralLocation
London, Eng.Publisher DOI
eISSN
1745-6215Language
engPublication classification
C Journal article; C1 Refereed article in a scholarly journalCopyright notice
2014, BioMed CentralUsage metrics
Read the peer-reviewed publication
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalResearch & Experimental MedicineAdolescenceAntidepressantsCognitive behavioural therapyDepressionFluoxetineSelective serotonin reuptake inhibitorsYouthPLACEBO-CONTROLLED TRIALMAJOR DEPRESSIONDOUBLE-BLINDANTIDEPRESSANT TREATMENTCOMMUNITY SAMPLESELF-REPORTADOLESCENTSCHILDRENDISORDERPSYCHOTHERAPY